Andreas G. Bader - Concepedia

Author

Andreas G. Bader

Mirna Therapeutics (United States)

Also Known As

A G Bader, A. Bader, A.G. Bader, Andreas Bader, Andreas G Bader, Andreas G. Bader, Bader, A., Bader, Andreas

116

Publications

11.9K

Citations

H-Index

Concepts

All Affiliations

Mirna Therapeutics (United States)The University of Texas MD Anderson Cancer Center Scripps Research Institute The University of Texas Health Science Center at San Antonio Mayo Clinic in Arizona

About

Andreas G. Bader is an author at Mirna Therapeutics (United States) specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	19	5.8K
2	Natural Sciences	3	3	225
3	Health Sciences	2	2	2.1K
4	Engineering	1	1	24
5	Biostatistics	1	1	24

Andreas G. Bader

Publications

9.7K

Citations

H-Index

Page 1

	Year	Citations
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 Can Liu, Kevin Kelnar, Bigang Liu, Nature Medicine Microrna Mir-34a InhibitsMedicineStem CellsCancer Cell BiologyStem Cell Research	2011	1.4K
Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors Muhammad S. Beg, Andrew Brenner, Jasgit C. Sachdev, Investigational New Drugs Tumor BiologyMedicinePathologyAdvanced Solid TumorsExtracellular Microvesicles	2016	855
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours David S. Hong, Yoon‐Koo Kang, Mitesh J. Borad, British Journal of Cancer	2020	850
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic Sohye Kang, Andreas G. Bader, Peter K. Vogt Proceedings of the National Academy of Sciences Phosphatidylinositol 3-Kinase MutationsTumor BiologySignaling PathwayCell RegulationReceptor Tyrosine Kinase	2005	821
miR-34 – a microRNA replacement therapy is headed to the clinic Andreas G. Bader Frontiers in Genetics Mir-34 –PathologyCancer BiologyTumor BiologyTumor Heterogeneity	2012	721
Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34 Jason F. Wiggins, Lynnsie Ruffino, Kevin Kelnar, Cancer Research	2010	686
PDL1 Regulation by p53 via miR-34 María Angélica Cortez, Cristina Ivan, David R. Valdecanas, JNCI Journal of the National Cancer Institute	2015	657
Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice Phong Trang, Jason F. Wiggins, Christopher Daige, Molecular Therapy	2011	654
The<i>let-7</i>microRNA reduces tumor growth in mouse models of lung cancer Aurora Esquela‐Kerscher, Phong Trang, Jason F. Wiggins, Cell Cycle Cancer WorldwideImmunologyCancer BiologyTumor BiologyOncology	2008	589
Regression of murine lung tumors by the let-7 microRNA Phong Trang, Pedro P. Medina, Jane F. Wiggins, Oncogene Murine Lung TumorsPathologySmall RnaMicrorna DetectionMedicine	2009	495

Page 1